Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849348) titled 'Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Peking University People's Hospital
Condition:
Obesity
Chronic Kidney Disease
Albuminuria
Intervention:
Drug: Finerenone
Drug: Finerenone Placebo
Recruitment Status: Not recruiting
Pha...